K. Imafuku

发表

Drp1 regulates mitochondrial morphology and cell proliferation in cutaneous squamous cell carcinoma.

H. Shimizu, R. Abe, H. Hata, 2017, Journal of dermatological science.

Ultrasound B‐mode and elastographic findings of mixed tumour of the skin on the scalp

H. Shimizu, H. Hata, H. Iwata, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

“Sprinkle brightness lesion” appearance in ultrasound B‐mode findings of sinusoidal hemangioma

H. Shimizu, H. Hata, W. Nishie, 2014, The Journal of dermatology.

Two Cases of Nivolumab Re-Administration after Pneumonitis as Immune-Related Adverse Events

H. Hata, K. Ohara, K. Yoshino, 2017, Case Reports in Oncology.

Loss of dynamin-related protein 1 (Drp1) does not affect epidermal development or UVB-induced apoptosis but does accelerate UVB-induced carcinogenesis.

H. Shimizu, R. Abe, H. Sesaki, 2020, Journal of dermatological science.

Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma

Muhammad Baghdadi, H. Hata, K. Seino, 2018, Inflammation and regeneration.

PCTAIRE1/CDK16/PCTK1 is overexpressed in cutaneous squamous cell carcinoma and regulates p27 stability and cell cycle.

H. Shimizu, Lei Wang, H. Hata, 2017, Journal of dermatological science.

Baseline neutrophil to lymphocyte ratio combined with serum LDH level associated with outcome of nivolumab immunotherapy in a Japanese advanced melanoma population

Y. Fujisawa, T. Funakoshi, A. Otsuka, 2018 .

Using immune checkpoint inhibitors without exacerbation in a melanoma patient with pemphigus foliaceus

H. Shimizu, H. Hata, K. Izumi, 2017, International journal of dermatology.

Successful Treatment of Sudden Hepatitis Induced by Long-Term Nivolumab Administration

H. Hata, K. Ohara, K. Yoshino, 2017, Case Reports in Oncology.

Isolated adrenocorticotropic hormone deficiency associated with nivolumab therapy

H. Shimizu, H. Miyoshi, A. Nakamura, 2017, The Journal of dermatology.

Hypothyroidism associated with nivolumab treatment of unresectable malignant melanoma

H. Hata, K. Ohara, K. Yoshino, 2017, Clinical and experimental dermatology.

H. Shimizu, H. Hata, C. Nakayama, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

Ultrasonographic features of intravascular fasciitis: case report and review of the literature

H. Shimizu, H. Hata, S. Kitamura, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Seborrheic keratosis arising on an epidermal nevus with HRAS p.G13R mutation

H. Shimizu, H. Hata, H. Nishihara, 2017, International journal of dermatology.

A black nodule on the temple

H. Shimizu, H. Hata, K. Imafuku, 2016 .

Six-month History of a Split Thumbnail: A Quiz.

H. Shimizu, H. Ujiie, K. Imafuku, 2018, Acta dermato-venereologica.

Multiple skin cancers in patients with mycosis fungoides after long‐term ultraviolet phototherapy

H. Shimizu, H. Hata, S. Kitamura, 2017, Clinical and experimental dermatology.

A case of erythroplasia of Queyrat successfully treated with combination carbon dioxide laser vaporization and surgery

H. Shimizu, H. Hata, S. Kitamura, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

Pazopanib does not bring remarkable improvement in patients with angiosarcoma

H. Shimizu, H. Hata, K. Yoshino, 2017, The Journal of dermatology.

Retrospective study of advanced melanoma patients treated with ipilimumab after nivolumab: Analysis of 60 Japanese patients.

Y. Fujisawa, H. Uchi, A. Otsuka, 2018, Journal of dermatological science.

Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study

Y. Fujisawa, S. Aiba, H. Uchi, 2018, Oncotarget.

Serum Level of Soluble CD163 May Be a Predictive Marker of the Effectiveness of Nivolumab in Patients With Advanced Cutaneous Melanoma

Y. Fujisawa, S. Aiba, H. Uchi, 2018, Front. Oncol..

Fluctuations in routine blood count might signal severe immune-related adverse events in melanoma patients treated with nivolumab.

Y. Fujisawa, A. Otsuka, M. Gosho, 2017, Journal of dermatological science.

Japanese Dermatological Association Guidelines: Outlines of guidelines for cutaneous melanoma 2019

H. Koga, H. Igaki, S. Fukushima, 2019, The Journal of dermatology.

Zonula occludens-1 demonstrates a unique appearance in buccal mucosa over several layers

H. Shimizu, Hideki Nakamura, K. Natsuga, 2021, Cell and Tissue Research.

Dermoscopic findings of irritated seborrheic keratosis

H. Shimizu, H. Hata, Y. Fujita, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

mTOR expression correlates with invasiveness and progression of extramammary Paget's disease

H. Shimizu, K. Natsuga, R. Abe, 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

Nivolumab therapy before vemurafenib administration induces a severe skin rash

H. Hata, K. Ohara, K. Yoshino, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

A case of linear basal cell carcinoma: evaluation of proliferative activity by immunohistochemical staining of PCTAIRE1 and p27

H. Shimizu, H. Hata, H. Nishihara, 2017, Journal of the European Academy of Dermatology and Venereology.

Adjuvant therapy with low‐dose interferon‐beta for stage II and III melanoma: results of a retrospective analysis

H. Shimizu, H. Hata, S. Kitamura, 2017, Clinical and experimental dermatology.

Severe rash associated with vemurafenib administration following nivolumab therapy

H. Hata, K. Ohara, K. Yoshino, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

Apocrine mixed tumour on the abdomen: an atypical location

H. Shimizu, T. Nomura, H. Hata, 2018, European Journal of Dermatology.

Lessons from 20 cases of digit malignant melanoma

H. Shimizu, H. Hata, S. Kitamura, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Sudden Onset of Brain Metastasis despite the Use of Vemurafenib for Another Metastatic Lesion in Malignant Melanoma Patients

H. Hata, K. Ohara, K. Yoshino, 2017, Case Reports in Oncology.

Ultrasonographic findings can identify ‘pseudoprogression’ under nivolumab therapy

H. Shimizu, H. Hata, S. Kitamura, 2017, The British journal of dermatology.

Autoantibodies of non‐inflammatory bullous pemphigoid hardly deplete type XVII collagen of keratinocytes

H. Shimizu, K. Natsuga, K. Izumi, 2017, Experimental dermatology.

Lipofuscin deposition causes the pigmentation of apocrine hidrocystoma

H. Shimizu, H. Hata, S. Kitamura, 2018, The Journal of dermatology.

Acrokeratoelastoidosis successfully treated with 10% salicylic acid ointment

H. Shimizu, H. Hata, Y. Fujita, 2017, The Journal of dermatology.

Pazopanib can preserve cosmetic quality of life even in end‐stage angiosarcoma

H. Shimizu, H. Hata, S. Kitamura, 2015, Clinical and experimental dermatology.

Subcutaneous Nodule on the Right Palm of a Young Boy: A Quiz.

H. Shimizu, T. Nomura, H. Hata, 2017, Acta Dermato-Venereologica.

Hemosiderotic histiocytoma associated with chronic traumatic stress in a patient with spinal cord injury

H. Shimizu, H. Hata, S. Kitamura, 2016, The Journal of dermatology.

Morphoeic basal cell carcinoma with ring‐form ulceration

H. Shimizu, H. Hata, S. Kitamura, 2016, International journal of dermatology.

Case of successfully switching from nivolumab to vemurafenib with oral corticosteroids

H. Hata, K. Ohara, K. Yoshino, 2018, The Journal of dermatology.

Two cases of successful treatment for severe skin rash induced by vemurafenib following nivolumab therapy without cessation of vemurafenib

K. Ohara, K. Yoshino, K. Imafuku, 2017, The Journal of dermatology.

Case of congenital panfollicular nevus with remarkable adipose tissue proliferation

H. Shimizu, H. Hata, S. Kitamura, 2017, The Journal of dermatology.

Positron emission tomography–computed tomography can be useful in the early detection of metastases in primary mucinous carcinoma of the skin on the head and neck

H. Shimizu, K. Hirata, H. Hata, 2015, The British journal of dermatology.

Zonula occludens‐1 distribution and barrier functions are affected by epithelial proliferation and turnover rates

Yasuaki Kobayashi, H. Kitahata, K. Natsuga, 2023, Cell proliferation.

Loss of TRIM29 Alters Keratin Distribution to Promote Cell Invasion in Squamous Cell Carcinoma.

H. Shimizu, S. Hatakeyama, Lei Wang, 2018, Cancer research.

Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma

Muhammad Baghdadi, H. Hata, K. Seino, 2018, Inflammation and regeneration.

In‐transit metastasis of advanced eccrine porocarcinoma

H. Shimizu, H. Hata, H. Iwata, 2015, International journal of dermatology.

Disappearing subcutaneous papules and nodules: Characteristic features of muscle herniation and piezogenic pedal papules

H. Shimizu, W. Nishie, K. Arita, 2017, The Journal of dermatology.

Retrospective study on the correlation between 18‐fluorodeoxyglucose uptake in positron emission tomography–computer tomography and tumour volume, cytological activity as assessed with Ki‐67 and GLUT‐1 staining in 10 cases of Merkel cell carcinoma

H. Shimizu, K. Hirata, H. Hata, 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

Metal implant‐induced skin ulcer mimicking scrofuloderma

H. Shimizu, K. Natsuga, S. Aoyagi, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

Dermoscopic features of Bednar tumor: Report of a case

H. Shimizu, T. Nomura, H. Hata, 2018, The Journal of dermatology.

Successful treatment of hidradenitis suppurativa with rituximab for a patient with idiopathic carpotarsal osteolysis and chronic active antibody‐mediated rejection

H. Shimizu, N. Shinohara, H. Hata, 2018, The Journal of dermatology.

Comment on ‘Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy'

H. Hata, K. Ohara, K. Yoshino, 2017, British Journal of Cancer.

Instructions for use Title Comment on ' Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastaticmelanoma after prior anti-PD-1 therapy '

K. Ohara, K. Yoshino, K. Imafuku, 2019 .

Modified Dufourmentel flap, easy to design and tailor to the defect

Hiroshi Shimizu, Keisuke Imafuku, Hiroo Hata, 2017, The Journal of dermatology.

Case of primary pleural angiosarcoma with malignant seeding along the pleural tap tract

K. Ohara, K. Yoshino, K. Imafuku, 2017, The Journal of dermatology.

Dermoscopic features of hidroacanthoma simplex: Usefulness in distinguishing it from Bowen's disease and seborrheic keratosis

H. Shimizu, H. Hata, S. Kitamura, 2015, Journal of dermatology (Print).

Pazopanib-Induced Severe Acute Pancreatitis

K. Kawakubo, H. Kawakami, M. Kuwatani, 2015, Case Reports in Oncology.

Bowen's disease on the palm presents refractory skin erosion without erythematous plaque

H. Shimizu, K. Natsuga, S. Aoyagi, 2015, The Journal of dermatology.

Comprehensive cancer-related gene analysis reveals that active KRAS mutation is a prognostic mutation in mycosis fungoides.

H. Shimizu, H. Hata, H. Nishihara, 2017, Journal of dermatological science.

Safety and dose-sparing effect of Japanese encephalitis vaccine administered by microneedle patch in uninfected, healthy adults (MNA-J): a randomised, partly blinded, active-controlled, phase 1 trial.

Takayoshi Oyamada, S. Takashima, K. Imafuku, 2021, The Lancet. Microbe.

A reddish nodule with viscous fluid secretion

H. Shimizu, H. Hata, S. Kitamura, 2016, International journal of dermatology.

Ultrasound B‐mode and elastographic findings of mixed tumour of the skin on the scalp

H. Shimizu, H. Hata, H. Iwata, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

The Unique Dermoscopic Structure ‘Large black web’ in basal cell carcinoma on the areola

H. Hata, S. Kitamura, T. Yanagi, 2016, Journal of the European Academy of Dermatology and Venereology.

Drp1 regulates mitochondrial morphology and cell proliferation in cutaneous squamous cell carcinoma.

H. Shimizu, R. Abe, H. Hata, 2017, Journal of dermatological science.

Super‐resolution imaging detects BP180 autoantigen in immunoglobulin M pemphigoid

H. Koga, K. Izumi, H. Ujiie, 2021, The Journal of dermatology.

PCTAIRE1/CDK16/PCTK1 is overexpressed in cutaneous squamous cell carcinoma and regulates p27 stability and cell cycle.

H. Shimizu, Lei Wang, H. Hata, 2017, Journal of dermatological science.